Picture of Edwards Lifesciences logo

EW Edwards Lifesciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Edwards Lifesciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,0478231,5031,5221,399
Depreciation
Deferred Taxes
Non-Cash Items235131-9.7233150
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-20442.2145-421-526
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities1,1791,0541,7321,218896
Capital Expenditures-278-407-330-265-266
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-317-124-1,393517440
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-596-531-1,723252174
Financing Cash Flow Items-2.8-1.2-0.3-3.6-1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-116-487-356-1,585-711
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash46515.8-333-94.8375